# US Food Allergy Diagnosis and Treatment Market

> U.S.s Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies) and By Age Group (Children, Adults, Elderly) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.89%
- **2024:** $ 421.4 Million
- **2025:** $ 453.5 Million
- **2035:** $ 877.1 Million
- **Key Players:** Thermo Fisher Scientific (US), Abbott Laboratories (US), Danone (US), Nestle(US), Bayer AG (US), Aimmune Therapeutics (US), DBV Technologies (US), Allergan (US), Merck & Co. (US)

**Report ID:** MRFR/HC/51543-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-food-allergy-diagnosis-and-treatment-market-53304

---

## Market Summary

## **US Food Allergy Diagnosis and Treatment Market Overview**

As per MRFR analysis, the US Food Allergy Diagnosis and Treatment Market Size was estimated at 1.8 (USD Billion) in 2024.The US Food Allergy Diagnosis and Treatment Market Industry is expected to grow from 1.91(USD Billion) in 2025 to 4 (USD Billion) by 2035. The US Food Allergy Diagnosis and Treatment Market CAGR (growth rate) is expected to be around 6.933% during the forecast period (2025 - 2035)

**Key US Food Allergy Diagnosis and Treatment Market Trends Highlighted**

The US Food Allergy Diagnosis and Treatment Market is experiencing significant growth due to rising food allergies among the population. Factors such as an increase in prevalence rates, particularly among children, have led to greater awareness and demand for effective diagnostic tools and treatments. The market is driven by advancements in testing technology, including the development of more precise and faster allergy tests, which allow for earlier diagnosis and management of food allergies. Additionally, the shift towards personalized medicine is encouraging the creation of tailored treatment plans for individuals based on their unique allergy profiles.

There are ample opportunities to be explored within the market, particularly in the areas of education and awareness programs. As parents and caregivers become more informed about food allergies, they demand better solutions and services. Furthermore, the rising trend of home-based monitoring and treatment solutions through mobile applications and wearable technology offers a chance for companies to engage with consumers more directly and revolutionize how food allergies are managed. Recent trends indicate a growing interest in immunotherapy options as viable treatments for food allergies, with new therapies being developed and tested.

Organizations in the U.S. are focusing on improving food labeling regulations and safety standards to help individuals manage allergies effectively. These developments reflect a commitment to reducing the risk associated with allergens in food products and creating environments that are safer for individuals with food allergies. As a result, this market is poised for continued growth, driven by innovation, consumer demand, and regulatory support, making it a critical area for healthcare providers and industry stakeholders to focus on.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**US Food Allergy Diagnosis and Treatment Market Drivers**

**Increasing Prevalence of Food Allergies Among the U.S. Population**

The rising incidence of food allergies in the United States is a significant driver for the US Food Allergy Diagnosis and Treatment Market Industry. According to the Centers for Disease Control and Prevention (CDC), food allergies not only affect approximately 8% of children but also seem to be on the rise, with reports showing a 50% increase in food allergy prevalence between 1997 and 2011. Research from the American College of Allergy, Asthma and Immunology suggests this increase is impacting millions of families, leading to an increased demand for accurate diagnosis and effective treatment options.

The increasing number of people impacted, especially children, is encouraging pharmaceutical companies and healthcare providers to allocate more resources to Research and Development work, increasing innovation with therapeutics and diagnostic tools aimed at food allergies. This increase in prevalence indicates that there is a strong market demand, enabling stakeholders to invest additional resources into ancillary services, which fosters sustainable growth for the industry.

**Advancements in Diagnostic Technologies**

Technological advancements in the field of diagnostics are a significant growth factor for the US Food Allergy Diagnosis and Treatment Market Industry. Innovations such as blood tests, skin prick tests, and more sophisticated immunoassays have emerged, improving the accuracy of food allergy diagnosis. The American Academy of Allergy, Asthma, and Immunology reports that with the development of these advanced methodologies, healthcare providers are now better equipped to identify specific allergies, which directly leads to better patient management. This has allowed for earlier diagnosis and interventions, laying the groundwork for new treatment strategies and ultimately expanding market opportunities.

As companies continue to invest in Research and Development of these technologies, the market is expected to grow significantly.

**Rising Awareness and Education About Food Allergies**

The increase in awareness and education regarding food allergies is fundamental in driving growth within the US Food Allergy Diagnosis and Treatment Market Industry. Various organizations, such as the Food Allergy Research and Education (FARE), are spearheading campaigns to raise public awareness and provide educational resources about the importance of food allergy recognition and management. This awareness has led to more individuals seeking medical advice and diagnosis, thereby increasing the number of patients entering the healthcare system.

For instance, educational initiatives have driven over 65% of parents to consult with healthcare professionals for allergies in children, as noted by the National Institute of Allergy and Infectious Diseases. Since more people are becoming proactive in managing food allergies, there is a newfound investment opportunity for healthcare providers and pharmaceutical companies, signaling positive growth trends in the market.

**US Food Allergy Diagnosis and Treatment Market Segment Insights**

**Food Allergy Diagnosis and Treatment Market Diagnosis Method Insights**

The US Food Allergy Diagnosis and Treatment Market has been experiencing significant growth, particularly within the Diagnosis Method segment, which plays a crucial role in identifying varying food allergies in individuals. The importance of accurate diagnosis cannot be overstated, as it guides appropriate treatment plans and dietary adjustments necessary for individuals suffering from allergies. Among the prevalent methods used, the Skin Prick Test stands out for its efficiency and reliability. It allows healthcare professionals to quickly assess allergic sensitivities by introducing allergens into the skin and observing the resulting reaction.

This method is widely accepted due to its rapid results and ease of use, making it a preferred choice for initial screening.

On the other hand, Blood Tests also hold a significant place in the Diagnosis Method segment. These tests help in determining specific allergen-related antibodies, offering a more comprehensive analysis for individuals with complex allergy profiles. This method not only provides an alternative for those who might react adversely to skin testing but also reinforces the accuracy of diagnosis through quantifiable data.

Oral Food Challenges are another critical approach that exemplifies a definitive method for diagnosis. By medically supervised exposure to potential allergens, this technique aids significantly in confirming or ruling out food allergies. It is particularly vital in cases where other tests yield inconclusive results, allowing for clarity and informed decisions regarding dietary management.

Elimination Diets serve as an essential strategy as well; although more time-consuming, they involve eliminating suspected allergenic foods from the diet for a specified duration, followed by gradual reintroduction to monitor reactions. This method is often favored for its thoroughness, providing insights into the patient's unique allergy profile.

As the U.S. grapples with a rising prevalence of food allergies, driven by factors such as genetic predisposition and environmental influences, the advancements in Diagnosis methods remain paramount. Each methodology offers distinct advantages, enabling healthcare providers to tailor their approaches based on individual patient needs. The continuous evolution and integration of new diagnostic technologies further enhance the capacity to provide precise and effective care in the US Food Allergy Diagnosis and Treatment Market, ensuring that individuals receive the appropriate interventions to manage their conditions effectively.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Food Allergy Diagnosis and Treatment Market Treatment Type Insights**

The Treatment Type segment of the US Food Allergy Diagnosis and Treatment Market plays a pivotal role in addressing the growing concern of food allergies, affecting millions across the nation. Medication remains one of the primary methods for managing allergy symptoms, offering essential relief to patients, while immunotherapy is gaining traction as a long-term solution with the potential to desensitize individuals to specific allergens. Dietary Management is essential, as patients are advised to avoid allergens, posing challenges that necessitate personalized plans to ensure nutritional adequacy.

Emergency Treatment Devices, such as auto-injectors, are critical for life-threatening situations, providing immediate access to treatment and generating a sense of security for those at risk. As awareness of food allergies increases, the segment is expected to evolve, with investments driven by technological advancements and a focus on patient-centric solutions. The combined efforts in these areas not only aim to mitigate the prevalence of food allergies but also emphasize a comprehensive approach to managing this chronic condition within the U.S. population, ensuring better quality of life and safety for those affected.

**Food Allergy Diagnosis and Treatment Market End User Insights**

The end-user segment of the US Food Allergy Diagnosis and Treatment Market is characterized by a diverse landscape that includes Hospitals, Clinics, Home Care, and Pharmaceutical Companies, each playing a critical role in delivering effective care. Hospitals are notably important as they often provide comprehensive diagnostic and treatment services, equipped with advanced technologies and specialized staff, which enables them to handle complex food allergy cases. Clinics, with their focused expertise, serve as convenient access points for rapid testing and ongoing management of food allergies, catering to the growing need for immediate healthcare solutions.

The Home Care market segment is gaining traction, particularly as patients seek more personalized and flexible treatment options, representing a significant trend towards self-management of food allergies. Pharmaceutical Companies contribute considerably by developing innovative therapies and medications that address food allergies, driving advancements in the field. This segment's dynamics reflect a growing recognition of food allergies as a public health concern, with increasing investment and research aimed at improving diagnostic accuracy and treatment efficacy, further enhancing the overall landscape of the US Food Allergy Diagnosis and Treatment Market.

**Food Allergy Diagnosis and Treatment Market Age Group Insights**

The Age Group segmentation within the US Food Allergy Diagnosis and Treatment Market reveals distinct dynamics across different demographics. The landscape comprises children, adults, and the elderly, each presenting unique challenges and opportunities. Children account for a significant proportion of food allergy cases, often facing severe reactions that necessitate immediate medical attention and ongoing management strategies; addressing their needs is crucial for preventing serious health complications. Adults, on the other hand, frequently deal with the continued impact of allergies formed during childhood, which can lead to a fluctuating quality of life and increased healthcare expenses.

The elderly population may experience food allergies differently, as the effects can be exacerbated by age-related factors and comorbidities, necessitating tailored approaches to diagnosis and treatment. Overall, the diverse needs across these age groups drive innovation and strategy in the food allergy sector, underpinning the increasing demand for customized treatment solutions and preventive measures, making it an essential area of focus within the broader US Food Allergy Diagnosis and Treatment Market industry.

With a steady increase in awareness and advances in medical technology, there are considerable opportunities for growth in addressing the needs of these specific age groups, helping to improve health outcomes and the quality of life for individuals affected by food allergies across the U.S.

**US Food Allergy Diagnosis and Treatment Market Key Players and Competitive Insights**

The US Food Allergy Diagnosis and Treatment Market is a rapidly evolving sector marked by a growing prevalence of food allergies among all age groups. With increasing awareness and advancements in medical technologies, the competitive landscape is characterized by innovation in both diagnostic and therapeutic solutions. Companies within this market are focusing on enhancing patient outcomes through tailored approaches that range from lifestyle management to cutting-edge treatments. The dynamic interplay between established players and emerging start-ups is driving investments in research and development, with a keen emphasis on developing comprehensive methods for managing food allergies.

As the market continues to grow, strategic partnerships and collaborations are becoming increasingly common as companies aim to leverage collective expertise and resources. Stateside Foods has established itself as a noteworthy player in the US Food Allergy Diagnosis and Treatment Market, focusing on creating food products specifically tailored for individuals with food allergies. The company has maintained a strong market presence by prioritizing safety and allergen-free formulations, which resonate with consumers seeking safe dietary options. Stateside Foods has effectively utilized rigorous testing and quality control measures to enhance its reputation among healthcare providers and consumers alike.

Their commitment to education regarding food allergies and symptom management contributes to their competitive edge, enabling them to form long-lasting relationships with both customers and healthcare professionals. The brand's unique value proposition lies in its ability to offer delicious and safe food alternatives that not only meet dietary restrictions but also appeal to broader consumer preferences. Bristol Myers Squibb is a prominent entity in the US Food Allergy Diagnosis and Treatment Market, known for its development of innovative therapies and biopharmaceuticals that address food allergies.

The company boasts a robust portfolio that includes targeted treatments aimed at desensitization and improved patient management. Bristol Myers Squibb’s extensive research initiatives and collaborations with academic institutions have significantly advanced the understanding of food allergies, thereby fostering a pipeline of breakthrough products. Their strength lies not only in their comprehensive product offerings but also in their significant investments in mergers and acquisitions that expand their capabilities in allergy management.

The company's commitment to enhancing patient care through innovative solutions is evident in their proactive approach toward R&D, which strives to meet the growing demand for effective food allergy management in the U.S. market.

**Key Companies in the US Food Allergy Diagnosis and Treatment Market Include**

**US Food Allergy Diagnosis and Treatment Market Industry Developments**

Recent developments in the US Food Allergy Diagnosis and Treatment Market highlight a growing focus on innovative therapies and diagnostic solutions. In recent months, companies like DBV Technologies and Aimmune Therapeutics have made strides in allergy immunotherapy, as evidenced by the advancement of peanut allergen treatments. In October 2023, Eli Lilly announced an enhancement in their research initiatives to develop potential treatments for food allergies, focusing on better patient outcomes and safety profiles. Furthermore, Johnson and Johnson continues to expand its portfolio in food allergy diagnostics through strategic partnerships aimed at improving testing accuracy.

The market has also seen significant growth, with Stateside Foods and Nestle contributing to developments that emphasize allergen-free products, reflecting consumer demand for safer food options. Notably, in August 2023, Thermo Fisher Scientific made headlines for introducing new diagnostic tools that promise faster and more precise allergy testing, impacting physician practices nationwide. Last year, in September 2022, GSK invested heavily in Research and Development aimed at innovative solutions for food allergies, signifying a commitment to capturing a larger share of this expanding market.

Overall, the US Food Allergy Diagnosis and Treatment Market is witnessing robust evolution and investment, setting a positive trajectory for future advancements.

**Food Allergy Diagnosis And Treatment Market Segmentation Insights**

**Food Allergy Diagnosis and Treatment Market Diagnosis Method Outlook**

**Food Allergy Diagnosis and Treatment Market Treatment Type Outlook**

**Food Allergy Diagnosis and Treatment Market End User Outlook**

**Food Allergy Diagnosis and Treatment Market Age Group Outlook**

## Market Drivers

### Regulatory Support and Guidelines

The US Food Allergy Diagnosis Treatment Market benefits from supportive regulatory frameworks and guidelines established by organizations such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). These agencies have implemented policies aimed at improving food allergy diagnosis and management, which fosters innovation in the market. For instance, the FDA has approved several new diagnostic tests and treatment options, enhancing the overall landscape of food allergy management. Furthermore, the establishment of guidelines for allergen labeling and food safety practices has created a conducive environment for market growth. This regulatory support is likely to encourage investment in research and development, ultimately benefiting patients and healthcare providers.

### Rising Prevalence of Food Allergies

The US Food Allergy Diagnosis Treatment Market is experiencing growth due to the increasing prevalence of food allergies among the population. Recent estimates suggest that food allergies affect approximately 32 million Americans, including 5.6 million children. This rising incidence necessitates improved diagnostic and treatment options, driving demand for innovative solutions. As awareness of food allergies grows, healthcare providers are more likely to invest in advanced diagnostic tools and treatment modalities. The increasing number of allergic reactions and anaphylaxis cases further emphasizes the need for effective management strategies. Consequently, the market is poised for expansion as stakeholders seek to address this pressing public health concern.

### Technological Innovations in Diagnostics

Technological advancements play a crucial role in shaping the US Food Allergy Diagnosis Treatment Market. Innovations such as skin prick tests, blood tests, and component-resolved diagnostics have revolutionized the way food allergies are diagnosed. These technologies enable healthcare professionals to identify specific allergens with greater accuracy and speed, leading to more effective treatment plans. The integration of artificial intelligence and machine learning in diagnostic tools is also emerging, potentially enhancing the precision of allergy testing. As these technologies continue to evolve, they are expected to drive market growth by improving patient outcomes and streamlining the diagnostic process.

### Growing Demand for Allergen-Free Products

The US Food Allergy Diagnosis Treatment Market is witnessing a surge in demand for allergen-free products, driven by the increasing awareness of food allergies among consumers. As individuals become more conscious of their dietary choices, there is a growing market for foods that are free from common allergens such as peanuts, tree nuts, dairy, and gluten. This trend is prompting food manufacturers to innovate and develop allergen-free alternatives, which in turn drives the need for effective diagnosis and treatment options. The rise of allergen-free products not only reflects changing consumer preferences but also highlights the importance of accurate diagnosis and management of food allergies, further propelling market growth.

### Increased Investment in Research and Development

Investment in research and development (R&D) is a key driver of the US Food Allergy Diagnosis Treatment Market. Pharmaceutical companies and biotechnology firms are increasingly focusing on developing novel therapies and diagnostic tools for food allergies. This trend is supported by funding from government agencies and private organizations, which aim to advance the understanding of food allergies and improve treatment options. The potential for breakthrough therapies, such as oral immunotherapy and biologics, is attracting significant interest from investors. As R&D efforts continue to expand, the market is likely to benefit from the introduction of innovative solutions that address the unmet needs of patients with food allergies.

## Future Outlook

The US Food Allergy Diagnosis Treatment Market is projected to grow at a 6.89% CAGR from 2025 to 2035, driven by increasing prevalence of food allergies, advancements in diagnostic technologies, and rising consumer awareness.

**New opportunities:**

- Development of mobile diagnostic applications for real-time allergy testing. Expansion of [telehealth](https://www.marketresearchfuture.com/reports/telehealth-market-900)services for remote allergy consultations. Investment in personalized treatment plans leveraging genetic profiling.

By 2035, the market is expected to be robust, driven by innovation and increased consumer engagement.

## Segment Insights

### By Diagnosis Method: Skin Prick Test (Largest) vs. Oral Food Challenge (Fastest-Growing)

In the US Food Allergy Diagnosis Treatment Market, the 'Skin Prick Test' holds the largest share due to its widespread adoption among healthcare professionals and patients alike. This method is favored for its immediacy and ease of use, allowing healthcare providers to quickly assess allergic reactions to specific allergens. In contrast, 'Blood Test' and 'Patch Test' account for smaller shares, employed in specific cases based on patient history or particular allergies. Meanwhile, the 'Oral Food Challenge', while traditionally less common, is gaining traction as an emerging method that provides crucial and definitive data about food allergies and tolerance levels. The growth of the diagnosis methods segment in this market is influenced by several key trends. The increasing prevalence of food allergies in the population is driving demand for accurate and efficient testing methods. Doctors and allergists are increasingly turning to more complex testing regimes involving the 'Oral Food Challenge' to overcome the limitations of traditional tests. Furthermore, advancements in technology and increased awareness about food allergies are enabling broader access to these diagnostics, particularly in specialized clinics, thereby contributing to the rapid growth of the fastest-growing segment of the market.

Skin Prick Test (Dominant) vs. Blood Test (Emerging)

The 'Skin Prick Test' is the dominant method in the US Food Allergy Diagnosis Treatment Market, characterized by its immediacy, cost-effectiveness, and reliability in evaluating allergic reactions. It allows for rapid assessment and is widely accepted among patients and healthcare providers. In contrast, the 'Blood Test' serves as an emerging option, gaining popularity for its ability to quantify specific IgE antibodies, thus providing a more comprehensive understanding of allergen sensitivity. This method, while generally more expensive than skin testing, appeals to patients who may prefer a non-invasive approach. As awareness about food allergies continues to rise, the integration of blood tests into diagnostic protocols is likely to expand, offering a more holistic view of patients' allergic profiles.

### By Treatment Type: Avoidance (Largest) vs. Immunotherapy (Fastest-Growing)

In the US Food Allergy Diagnosis Treatment Market, the segment values exhibit a diverse distribution of market share. Avoidance stands as the largest treatment type, as it emphasizes the primary strategy of evading allergens to mitigate allergic reactions. Meanwhile, medication and dietary management also hold notable positions, catering to users seeking pharmaceutical support and specialized dietary plans. The emergence of immunotherapy, though currently smaller in market share, showcases significant growth potential due to increasing acceptance and advancements in treatment methodologies. Growth trends within this segment are driven by rising awareness about food allergies and the importance of personalized treatment plans. Immunotherapy, in particular, has gained traction as research reveals its potential in desensitizing patients and providing long-term relief. Furthermore, the increasing prevalence of food allergies, particularly among children, propels the demand for effective management approaches, engaging both medication and dietary management strategies to support patients' quality of life.

Avoidance: Dominant vs. Immunotherapy: Emerging

The avoidance treatment type predominates as the primary means of managing food allergies in the United States. This approach focuses on steering clear of known allergens and is widely adopted due to its simplicity and effectiveness, making it a familiar choice among patients and caregivers. On the other hand, immunotherapy emerges as an innovative alternative, gaining momentum as a promising treatment strategy. By gradually exposing patients to increasing doses of allergens, this method aims to modify the immune response and enhance tolerance. Its expanding acceptance is fueled by continued research showcasing its efficacy in long-term management of food allergies, positioning it as a crucial complement to traditional avoidance strategies.

### By Patient Age Group: Children (Largest) vs. Adults (Fastest-Growing)

In the US Food Allergy Diagnosis Treatment Market, the patient age group segment is primarily dominated by children, who account for the largest share of diagnoses and treatments. This can be attributed to the rising awareness and improved screening processes, leading to an increase in identified food allergies among younger populations. Adults follow as a substantial part of the market, reflecting a steady recognition of food allergies and a growing number of adult diagnoses indicating changing dietary habits and lifestyle factors.

Children (Dominant) vs. Adults (Emerging)

Children represent the dominant segment in the US Food Allergy Diagnosis Treatment Market due to a higher incidence of food allergies diagnosed at a younger age. Factors such as increased parental awareness, advocacy for early testing, and initiatives in schools contribute to this large market share. Meanwhile, the adult segment is emerging as a significant player, driven by growing health consciousness and the rise in food allergies that were previously unidentified. Adults are increasingly seeking diagnostic treatments, paving the way for targeted solutions that cater to their specific needs.

### By Severity Level: Severe (Largest) vs. Mild (Fastest-Growing)

In the US Food Allergy Diagnosis Treatment Market, the distribution of market share across severity levels reveals that severe food allergies hold the largest share. This segment is characterized by a higher demand for specialized treatment options, driven by the greater risks associated with severe allergic reactions. Moderate allergies occupy a middle ground, contributing significantly to the market, while mild allergies, although they represent the smallest share currently, exhibit rapid growth as awareness and diagnosis improve. The growth trends within this segment show a notable shift toward increased diagnosis and treatment options for mild allergies, which are often underdiagnosed. Drivers of this trend include heightened public awareness and education about food allergies, leading to more people seeking treatment. In contrast, the severe allergies segment continues to be driven by innovations in therapeutic options and the necessity of emergency treatments, sustaining its position as the largest segment in this market.

Severe (Dominant) vs. Mild (Emerging)

In the US Food Allergy Diagnosis Treatment Market, severe allergies represent the dominant segment due to the critical nature of their management and treatment. Individuals with severe allergies require immediate access to life-saving treatments, fostering significant investments in research and development of advanced therapies, diagnostic tools, and allergen immunotherapy. Conversely, mild allergies are emerging rapidly in market significance, influenced by rising awareness of food allergies among consumers and healthcare providers. This growing segment is increasingly attracting innovative treatment solutions aimed at improving quality of life for those affected. Both segments, while differing in severity and treatment needs, are essential in shaping the overall landscape of food allergy management in the US.

## Competitive Benchmarking

The Food Allergy Diagnosis Treatment Market is currently characterized by a dynamic competitive landscape, driven by increasing prevalence of food allergies and a growing demand for effective diagnostic solutions. Key players such as Thermo Fisher Scientific (US), Abbott Laboratories (US), and Aimmune Therapeutics (US) are strategically positioned to leverage innovation and technological advancements. These companies are focusing on enhancing their product offerings through research and development, thereby shaping the competitive environment. The emphasis on precision medicine and personalized treatment options appears to be a common thread among these firms, indicating a shift towards more tailored approaches in food allergy management.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Nestle (US) and DBV Technologies (US) is significant, as they continue to innovate and expand their product lines, thereby intensifying competition.
In December 2025, Thermo Fisher Scientific (US) announced the launch of a new line of allergy testing kits designed to provide rapid results for common food allergens. This strategic move is likely to enhance their market presence and cater to the growing demand for quick and reliable diagnostic solutions. The introduction of these kits may also position Thermo Fisher as a leader in the diagnostic space, potentially increasing their market share.
In November 2025, Abbott Laboratories (US) expanded its partnership with a leading biotechnology firm to develop a novel food allergy treatment. This collaboration is indicative of Abbott's commitment to innovation and could significantly enhance their product portfolio. The strategic importance of this partnership lies in its potential to accelerate the development of new therapies, thereby addressing unmet needs in the food allergy treatment landscape.
In October 2025, Aimmune Therapeutics (US) received FDA approval for its new oral immunotherapy product aimed at treating peanut allergies. This approval marks a pivotal moment for the company, as it not only validates their research efforts but also positions them competitively against other treatment options. The strategic importance of this approval cannot be overstated, as it opens new avenues for market penetration and revenue generation.
As of January 2026, current trends in the Food Allergy Diagnosis Treatment Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in diagnostic processes. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. Looking ahead, competitive differentiation is likely to evolve, with a pronounced shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This evolution suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly competitive market.

## Recent News & Developments

Recent developments in the US Food Allergy Diagnosis and Treatment Market highlight a growing focus on innovative therapies and diagnostic solutions. In recent months, companies like DBV Technologies and Aimmune Therapeutics have made strides in allergy immunotherapy, as evidenced by the advancement of peanut allergen treatments. In October 2023, Eli Lilly announced an enhancement in their research initiatives to develop potential treatments for food allergies, focusing on better patient outcomes and safety profiles. Furthermore, Johnson and Johnson continues to expand its portfolio in food allergy diagnostics through strategic partnerships aimed at improving testing accuracy.

The market has also seen significant growth, with Stateside Foods and Nestle contributing to developments that emphasize allergen-free products, reflecting consumer demand for safer food options. Notably, in August 2023, Thermo Fisher Scientific made headlines for introducing new diagnostic tools that promise faster and more precise allergy testing, impacting physician practices nationwide. Last year, in September 2022, GSK invested heavily in Research and Development aimed at innovative solutions for food allergies, signifying a commitment to capturing a larger share of this expanding market.

Overall, the US Food Allergy Diagnosis and Treatment Market is witnessing robust evolution and investment, setting a positive trajectory for future advancements.

## Report Scope

| MARKET SIZE 2024 | 421.4(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 453.5(USD Million) |
| MARKET SIZE 2035 | 877.1(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.89% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Thermo Fisher Scientific (US), Abbott Laboratories (US), Danone (US), Nestle (US), Bayer AG (US), Aimmune Therapeutics (US), DBV Technologies (US), Allergan (US), Merck & Co. (US) |
| Segments Covered | Diagnosis Method, Treatment Type, Patient Age Group, Severity Level |
| Key Market Opportunities | Integration of advanced diagnostic technologies enhances accuracy in the US Food Allergy Diagnosis Treatment Market. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative food allergy diagnosis and treatment solutions in the US market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US Food Allergy Diagnosis Treatment Market?**
A: The market valuation was 421.4 USD Million in 2024.

**Q: What is the projected market size for the US Food Allergy Diagnosis Treatment Market by 2035?**
A: The market is projected to reach 877.1 USD Million by 2035.

**Q: What is the expected CAGR for the US Food Allergy Diagnosis Treatment Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 6.89%.

**Q: Which companies are considered key players in the US Food Allergy Diagnosis Treatment Market?**
A: Key players include Thermo Fisher Scientific, Abbott Laboratories, Danone, Nestle, Bayer AG, Aimmune Therapeutics, DBV Technologies, Allergan, and Merck & Co.

**Q: What are the primary diagnosis methods used in the US Food Allergy Diagnosis Treatment Market?**
A: Primary diagnosis methods include Skin Prick Test, Blood Test, Oral Food Challenge, and Patch Test.

**Q: How did the Skin Prick Test perform in terms of market valuation in 2024?**
A: The Skin Prick Test had a market valuation of 100.0 USD Million in 2024.

**Q: What treatment types are available in the US Food Allergy Diagnosis Treatment Market?**
A: Available treatment types include Avoidance, Medication, Immunotherapy, and Dietary Management.

**Q: What was the market valuation for Avoidance treatment in 2024?**
A: Avoidance treatment had a market valuation of 150.0 USD Million in 2024.

**Q: How does the market for food allergy treatments vary by patient age group?**
A: The market segments by age group include Children, Adults, and Elderly, with valuations of 150.0, 200.0, and 71.4 USD Million respectively in 2024.

**Q: What are the market valuations for food allergy severity levels in 2024?**
A: Market valuations for severity levels were Mild at 126.42 USD Million, Moderate at 126.42 USD Million, and Severe at 168.56 USD Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-food-allergy-diagnosis-and-treatment-market-53304*